tci Medicare Compliance & Reimbursement - 2004 Issue 16

PHARMACEUTICALS: Date Set For Drugmakers To Hand Over Pricing Data

Government ready to ratchet up its scrutiny of Big Pharma.It's official: A new price reporting era has arrived for drug manufacturers. An interim final rule in the April 6 Federal Register requires all average sales prices for Medicare Part B covered drugs and biologicals to be reported each quarter to the Centers for Medicare & Medicaid Services - starting April 30. Set up by provisions in the reform bill, the ASP reporting requirements include certain oral anti-cancer and immunosuppressive drugs, drugs provided through the durable medical equipment benefit and drugs provided incident to a physician's service...

To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.


Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles
Access to this feature is available in the following products:
  • tci Medicare Compliance & Reimbursement +Archives

demo
request yours today
 subscribe
start today
 newsletter
free subscription

Thank you for choosing Find-A-Code, please Sign In to remove ads.